CLOSE X
Algo Trading
Home

Blogs

Stock Market Blogs

AMI Organics IPO - Check Issue Date, Price, Lot Size and Details August 31 2021Ami Organics IPO, Ami Organics IPO, Latest IPO

Visit Count: 844

Ami Organics IPO

Bidding for Ami Organics' Initial Public Offering (IPO) worth Rs 569.64 crore will begin on September 1, 2021. The public offering of the specialty chemical maker, which will be accessible until September 3, would include a fresh issue of 200 crore and an offer for sale (OFS) by existing investors such as Parul Chetankumar Vaghasia and Kiranben Girishbhai Chovatia which will contributed up to 369.64 crore. The price range has been set by the firm at Rs 603-Rs 610 per share. On September 14, Ami Organics' shares are expected to debut on both the NSE and the BSE.

Applicants to the public offering may bid for a minimum of one lot of 24 shares and a maximum of thirteen lots.

Ami Organics Limited, founded in 2004, is a leading research and development-driven maker of specialty chemicals. The company produces a variety of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, as well as materials for agrochemicals and fine chemicals.

Apply for Ami Organics Limited IPO at Indira Securities

Over 450 pharmaceutical intermediates have been produced by the business in 17 core therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti- Parkinson's, anti-depressant, and anti-coagulant. It serves over 150 customers (including foreign customers) directly in India and in 25 countries across the world, including Europe, the United States, China, Israel, Japan, and Latin America. With a total installed capacity of 6,060 MTPA, the corporation runs three manufacturing locations in Gujarat: Sachin, Ankleshwar, and Jhagadia.

Competitive strength

·         One of the major manufacturers of pharmaceutical intermediates.

·         Has a strong and diverse product offering with 450+ Pharma Intermediates spanning 17 therapeutic areas.

·         Extensive geographical coverage and a diverse customer base.

·         R&D, sales, and marketing capabilities. 

·         A past record of strong financial performance.

The issue's objectives include:

·         The repayment/prepayment of certain financial facilities obtained by our company.

·         Funding our company's working capital requirements.

·         General corporate objectives

The book running lead managers for the public issue are Axis Capital, Intensive Fiscal, and Ambit, and the registrar is Link Intime.

Vijaya Diagnostics, Penna Cement, Shri Bajrang Power, and Ispat are also planning to undergo initial public offerings in September.


COMMENTS
Form
Categories
Blog Enquiry

Prevent Unauthorized Transactions in your demat and trading account --> Update your Mobile Number/Email id with your Depository Participant and Stock Broker. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat/trading account directly from CDSL and Stock Exchanges on the same day.........issued in the interest of investors...

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your Mobile Number & Email Id with your Stock Broker/ Depository Participant and receive OTP directly from Depository on your Email Id and/ or Mobile Number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued by NSE vide. Circular No. NSE/INSP/45191 dated: July 31, 2020 and NSE/INSP/45534 and BSE vide Notice No. 20200731-7, dated: July 31, 2020 and 20200831- 45 dated: August 31, 2020 and dated: August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities/ MF/ Bonds in the Consolidated Account Statement issued by NSDL/ CDSL every month.

6. Risk disclosures RISK DISCLOSURES ON DERIVATIVES:

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html
We believe that an educated investor is a protected investor !!!

"As per the directives of CDSL and esteemed Exchanges, it has been made mandatory for every client to furnish their latest KYC details viz. Valid Mobile No., Email- Id & Income range on or before 31.05.2021 else your Account will be marked as Non Compliant and will be Freezed till the compliance of such requirement."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Dear Investor if you wish to revoke your un-executed eDis mandate, please mail us with ISIN and quantity on dp@indiratrade.com by today EOD."
REGISTRATION NOS:

INDIRA SECURITIES PVT.LTD. (SEBI REG.NO.):NSE TMID: 12866, BSE TMID: 663, CDSL DPID: 17000 SEBI REG. NO.: INZ000188930, MCX TM ID: 56470, NCDEX TM ID: 01277, CDSL REG. NO.: IN-DP-90-2015, CIN : U67120MH1996PTC160201

DISCLAIMER:

"INVESTMENT IN SECURITIES MARKET ARE SUBJECT TO MARKET RISKS, READ ALL THE RELATED DOCUMENTS CAREFULLY BEFORE INVESTING."

INVESTORS GRIEVANCE

Indrendu Joshi. Email: compliance@indiratrade.com. Call : 0731-4797275

Investor grievance complaint : complaint@indiratrade.com

INVESTOR CHARTER